Literature DB >> 8228761

Social epidemiology of chickenpox in two British national cohorts.

J I Pollock1, J Golding.   

Abstract

STUDY
OBJECTIVE: To provide a quantitative description of factors independently predictive of reported chickenpox infections in two national cohorts of British children.
DESIGN: Longitudinal cohort study design employing logistic regression analysis of data obtained in the 1970 British Births Survey (later to become the Child Health and Education Study, CHES), and the 1958 British Perinatal Mortality Survey (later to become the National Child Development Survey, NCDS). SETTINGS: One-week birth cohorts covering the whole of the United Kingdom. PARTICIPANTS: Data were obtained from questionnaires administered to the carers of 10,196 children born in the UK between 5 and 11 April 1970 (CHES) and 10,927 children born in the UK between 3 and 9 March 1958 (NCDS). These numbers consist of the whole of the surviving cohorts excluding those for whom data were incomplete. MEASUREMENTS: Biological, social, and medical factors in the parents and children, as recorded by the child's principle carer or from clinical notes. MAIN
RESULTS: Chickenpox by the age of 10 years was reported to be more common in the children of advantaged families (higher social class, higher parental education levels), with a higher prevalence in those parts of the United Kingdom normally associated with affluence, such as the South East and South West of England, and lower rates in Wales and Scotland. Chickenpox by 10 years was also associated with more crowding in the home. A similar but less marked pattern occurred for chickenpox by the age of 11 years in the 1958 NCDS cohort. This social distribution apparently reflected overall rather than age-specific susceptibility.
CONCLUSIONS: The national and international pattern of chickenpox epidemiology indicate that both social and climatological factors may be important in defining groups at risk. Further research is indicated if a vaccination service is to be implemented in this country.

Entities:  

Mesh:

Year:  1993        PMID: 8228761      PMCID: PMC1059792          DOI: 10.1136/jech.47.4.274

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  22 in total

1.  Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.

Authors:  C L Wong; S Castriciano; M A Chernesky; W E Rawls
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

2.  Acute appendicitis and dietary fibre: an alternative hypothesis.

Authors:  D J Barker
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-13

3.  Deaths from chickenpox in adults in Papua New Guinea.

Authors:  P Barss
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

4.  Varicella-zoster virus affecting immigrant nurses.

Authors:  I R Hastie
Journal:  Lancet       Date:  1980-07-19       Impact factor: 79.321

5.  The epidemiology of varicella in staff and students of a hospital in the tropics.

Authors:  A R Venkitaraman; T J John
Journal:  Int J Epidemiol       Date:  1984-12       Impact factor: 7.196

Review 6.  Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

7.  Facial scarring after varicella. A comparison with variola major and variola minor.

Authors:  Z Jezek; W Hardjotanojo; A G Rangaraj
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

8.  [Serological study of the occurrence of Herpesviridae in French Guyana].

Authors:  J D Poveda; M Babin; J F Bonnici; P du Pasquier; H J Fleury
Journal:  Bull Soc Pathol Exot Filiales       Date:  1986

9.  Biochemical transformation of mouse cells by varicella-zoster virus.

Authors:  K Yamanishi; Y Matsunaga; T Ogino; P Lopetegui
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  Antibody responses to varicella-zoster virus and the role of antibody in host defense.

Authors:  A A Gershon; S P Steinberg
Journal:  Am J Med Sci       Date:  1981 Jul-Aug       Impact factor: 2.378

View more
  6 in total

1.  Deterministic SIR (Susceptible-Infected-Removed) models applied to varicella outbreaks.

Authors:  J Ospina Giraldo; D Hincapié Palacio
Journal:  Epidemiol Infect       Date:  2007-07-26       Impact factor: 2.451

Review 2.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

Review 3.  Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.

Authors:  S W P Lakmini Daulagala; Faseeha Noordeen
Journal:  Virusdisease       Date:  2018-07-06

Review 4.  Analysis of social epidemiology research on infectious diseases: historical patterns and future opportunities.

Authors:  Justin M Cohen; Mark L Wilson; Allison E Aiello
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

5.  Fatal varicella zoster infection in a severe steroid dependent asthmatic patient receiving methotrexate.

Authors:  A H Morice; W K Lai
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

6.  Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.

Authors:  Gustavo H Dayan; María S Panero; Roberto Debbag; Ana Urquiza; Marta Molina; Susana Prieto; María Del Carmen Perego; Graciela Scagliotti; Diana Galimberti; Guillermo Carroli; Cristina Wolff; D Scott Schmid; Vladimir Loparev; Dalya Guris; Jane Seward
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.